α-Synuclein accumulation reduces GABAergic inhibitory transmission in a model of multiple system atrophy

Biochemical and Biophysical Research Communications

Volumn 428, Issue 3, 2012, Pages 348-353

  Ito, Hiroshi ^a   Nakayama, Kimiko ^a   Jin, Chenghua ^a   Suzuki, Yasuyo ^a   Yazawa, Ikuru ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Synuclein; Aminobutyric acid; Miniature inhibitory postsynaptic currents; Multiple system atrophy; Neurodegeneration

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA SYNUCLEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEPOLYMERIZATION; ELECTROPHYSIOLOGY; GABAERGIC TRANSMISSION; MICROTUBULE; MOUSE; NONHUMAN; OLIGODENDROGLIA; PATCH CLAMP; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE; WHOLE CELL;

ALPHA-SYNUCLEIN; ANIMALS; GABAERGIC NEURONS; HUMANS; MICE; MICE, TRANSGENIC; MICROTUBULES; MULTIPLE SYSTEM ATROPHY; SYNAPTIC TRANSMISSION; TUBULIN;

MUS; MUS MUSCULUS;

EID: 84869889300     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.057     Document Type: Article

References (28)

1. Graham J.G., Oppenheimer D.R. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 1969, 32:28-34.
2. Gilman S., Wenning G.K., Low P.A., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
3. Papp M.I., Kahn J.E., Lantos P.L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J. Neurol. Sci. 1989, 94:79-100.
4. Arima K., Uedma K., Sunohara A.K., et al. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol. (Berl) 1998, 96:439-444.
5. Tu P.H., Galvin J.E., Baba M., et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann. Neurol. 1998, 44:415-422.
6. Spillantini M.G., Crowther R., Jakes R., et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 1998, 251:205-208.
7. Spillantini M.G., Goedert M. The α-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann. NY Acad. Sci. 2000, 920:16-27.
8. Duda J.E., Lee V.M., Trojanowski J.Q. Neuropathology of synuclein aggregates. J. Neurosci. Res. 2000, 61:121-127.
9. Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2001, 2:492-501.
10. Kahle P.J., Neumann M., Ozmen L., et al. Hyperphosphorylation and insolubility of α-synuclein in transgenic mouse oligodendrocytes. EMBO Rep. 2002, 3:583-588.
11. Yazawa I., Giasson B.I., Sasaki R., et al. Mouse model of multiple system atrophy: α-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 2005, 45:847-859.
12. Shult C.W., Rockenstein E., Crews L.A., et al. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J. Neurosci. 2005, 25:10689-10699.
13. Nakayama K., Suzuki Y., Yazawa I. Microtubule depolymerization suppresses α-synuclein accumulation in a mouse model of multiple system atrophy. Am. J. Pathol. 2009, 174:1471-1480.
14. Nakayama K., Suzuki Y., Yazawa I. Binding of neuronal α-synuclein to β-III tubulin and accumulation in a model of multiple system atrophy. Biochem. Biophys. Res. Commun. 2012, 417:1170-1175.
15. Fortin D.L., Nemani V.M., Voglmaier S.M., et al. Neural activity controls the synaptic accumulation of alpha-synuclein. J. Neurosci. 2005, 25:10913-10921.
16. Gravel M., Di Polo A., Valera P.B., et al. Four-kilobase sequence of the mouse CNP gene directs spatial and temporal expression of lacZ in transgenic mice. J. Neurosci. Res. 1998, 53:393-404.
17. Gitler A.D., Shorter J. Prime time for alpha-synuclein. J. Neurosci. 2007, 27:2433-2434.
18. Maroteaux L., Scheller R.H. The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Brain Res. Mol. Brain Res. 1991, 11:335-343.
19. Clayton D.F., George J.M. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 1998, 21:249-254.
20. Hsu L.J., Mallory M., Xia Y., et al. Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development. J. Neurochem. 1998, 71:338-344.
21. Savitt J.M., Dawson V.L., Dawson T.M. Diagnosis and treatment of Parkinson disease: molecules to medicine. J. Clin. Invest. 2006, 116:1744-1754.
22. Larsen K.E., Schmitz Y., Troyer M.D., et al. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 2006, 26:11915-11922.
23. Nemani V.M., Lu W., Berge V., et al. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 2010, 65:66-79.
24. Abeliovich A., Schmitz Y., Fariñas I., et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000, 25:239-252.
25. Yavich L., Tanila H., Vepsäläinen S., et al. Role of alpha-synuclein in presynaptic dopamine recruitment. J. Neurosci. 2004, 24:11165-11170.
26. Scott D.A., Tabarean I., Tang Y., et al. A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration. J. Neurosci. 2010, 30:8083-8095.
27. Jeannotte A.M., Sidhu A. Regulated interactions of the norepineprhine transporter by the actin and microtubule cytoskeletons. J. Neurochem. 2008, 105:1668-1682.
28. Fleming S.M., Mulligan C.K., Richter F., et al. A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions. Mol. Cell. Neurosci. 2011, 46:597-606.